BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

185 related articles for article (PubMed ID: 21213409)

  • 1. Clarification of the phenotypic characteristics and anti-tumor activity of Hedyotis diffusa.
    Lee HZ; Bau DT; Kuo CL; Tsai RY; Chen YC; Chang YH
    Am J Chin Med; 2011; 39(1):201-13. PubMed ID: 21213409
    [TBL] [Abstract][Full Text] [Related]  

  • 2. The anti-tumor effect and bioactive phytochemicals of Hedyotis diffusa willd on ovarian cancer cells.
    Zhang L; Zhang J; Qi B; Jiang G; Liu J; Zhang P; Ma Y; Li W
    J Ethnopharmacol; 2016 Nov; 192():132-139. PubMed ID: 27426510
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Investigating the Multi-Target Pharmacological Mechanism of
    Song Y; Wang H; Pan Y; Liu T
    Biomolecules; 2019 Oct; 9(10):. PubMed ID: 31600936
    [No Abstract]   [Full Text] [Related]  

  • 4. Anticancer Effects of 1,3-Dihydroxy-2-Methylanthraquinone and the Ethyl Acetate Fraction of Hedyotis Diffusa Willd against HepG2 Carcinoma Cells Mediated via Apoptosis.
    Li YL; Zhang J; Min D; Hongyan Z; Lin N; Li QS
    PLoS One; 2016; 11(4):e0151502. PubMed ID: 27064569
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Development and validation of a modified ultrasound-assisted extraction method and a HPLC method for the quantitative determination of two triterpenic acids in Hedyotis diffusa.
    Yang YC; Wei MC; Chiu HF; Huang TC
    Nat Prod Commun; 2013 Dec; 8(12):1683-6. PubMed ID: 24555272
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Development of a simple chromatographic method for distinguishing between two easily confused species, Hedyotis diffusa and Hedyotis corymbosa.
    Lau CB; Cheng L; Cheng BW; Yue GG; Wong EC; Lau CP; Leung PC; Fung KP
    Nat Prod Res; 2012; 26(15):1446-50. PubMed ID: 21988612
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Reversal of P-glycoprotein-mediated multidrug resistance in human hepatoma cells by hedyotiscone A, a compound isolated from Hedyotis corymbosa.
    Yue GG; Kin-Ming Lee J; Cheng L; Chung-Lap Chan B; Jiang L; Fung KP; Leung PC; Bik-San Lau C
    Xenobiotica; 2012 Jun; 42(6):562-70. PubMed ID: 22352391
    [TBL] [Abstract][Full Text] [Related]  

  • 8. The Antitumor Constituents from Hedyotis Diffusa Willd.
    Wang C; Zhou X; Wang Y; Wei D; Deng C; Xu X; Xin P; Sun S
    Molecules; 2017 Nov; 22(12):. PubMed ID: 29189741
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Ursolic acid and its esters: occurrence in cranberries and other Vaccinium fruit and effects on matrix metalloproteinase activity in DU145 prostate tumor cells.
    Kondo M; MacKinnon SL; Craft CC; Matchett MD; Hurta RA; Neto CC
    J Sci Food Agric; 2011 Mar; 91(5):789-96. PubMed ID: 21351105
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Fingerprint of Hedyotis diffusa Willd. by HPLC-MS.
    Yang T; Yang YH; Yang JY; Chen BM; Duan JP; Yu SY; Ouyang HT; Cheng JP; Chen YX
    Phytochem Anal; 2008; 19(6):487-92. PubMed ID: 18446772
    [TBL] [Abstract][Full Text] [Related]  

  • 11. A comparable, chemical and pharmacological analysis of the traditional Chinese medicinal herbs Oldenlandia diffusa and O. corymbosa and a new valuation of their biological potential.
    Liang Z; He M; Fong W; Jiang Z; Zhao Z
    Phytomedicine; 2008 Apr; 15(4):259-67. PubMed ID: 18339527
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Antitumor potential of Hedyotis diffusa Willd: A systematic review of bioactive constituents and underlying molecular mechanisms.
    Han X; Zhang X; Wang Q; Wang L; Yu S
    Biomed Pharmacother; 2020 Oct; 130():110735. PubMed ID: 34321173
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Chemical Profiles and Protective Effect of Hedyotis diffusa Willd in Lipopolysaccharide-Induced Renal Inflammation Mice.
    Ye JH; Liu MH; Zhang XL; He JY
    Int J Mol Sci; 2015 Nov; 16(11):27252-69. PubMed ID: 26580602
    [TBL] [Abstract][Full Text] [Related]  

  • 14. 2-Hydroxy-3-methylanthraquinone from Hedyotis diffusa WILLD induces apoptosis via alteration of Fas/FasL and activation of caspase-8 in human leukemic THP-1 cells.
    Wang JH; Shu LH; Yang LL; Zhang M; He P
    Arch Med Res; 2011 Oct; 42(7):577-83. PubMed ID: 22108623
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Isolation, purification, structural characteristics, pharmacological activities, and combined action of Hedyotis diffusa polysaccharides: A review.
    Zhang R; Ma C; Wei Y; Wang X; Jia J; Li J; Li K; Cao G; Yang P
    Int J Biol Macromol; 2021 Jul; 183():119-131. PubMed ID: 33905802
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Systems pharmacology uncover the mechanism of anti-non-small cell lung cancer for Hedyotis diffusa Willd.
    Su X; Li Y; Jiang M; Zhu J; Zheng C; Chen X; Zhou J; Li Y; Xiao W; Wang Y
    Biomed Pharmacother; 2019 Jan; 109():969-984. PubMed ID: 30551551
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Cytotoxicity and bioavailability studies on a decoction of Oldenlandia diffusa and its fractions separated by HPLC.
    Ganbold M; Barker J; Ma R; Jones L; Carew M
    J Ethnopharmacol; 2010 Sep; 131(2):396-403. PubMed ID: 20633624
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Hedyotis Diffusa Willd extract induces apoptosis via activation of the mitochondrion-dependent pathway in human colon carcinoma cells.
    Lin J; Chen Y; Wei L; Chen X; Xu W; Hong Z; Sferra TJ; Peng J
    Int J Oncol; 2010 Nov; 37(5):1331-8. PubMed ID: 20878081
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Methylanthraquinone from Hedyotis diffusa WILLD induces Ca(2+)-mediated apoptosis in human breast cancer cells.
    Liu Z; Liu M; Liu M; Li J
    Toxicol In Vitro; 2010 Feb; 24(1):142-7. PubMed ID: 19686834
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Application of novel loop-mediated isothermal amplification (LAMP) for rapid authentication of the herbal tea ingredient Hedyotis diffusa Willd.
    Li M; Wong YL; Jiang LL; Wong KL; Wong YT; Lau CB; Shaw PC
    Food Chem; 2013 Dec; 141(3):2522-5. PubMed ID: 23870990
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 10.